Loading

DealSize | NVS - News

डैशबोर्ड

समाचार
कैलेंडर
ChartDS

मूल्य निर्धारण
ब्रोकर

मैं आपकी कैसे मदद कर सकता हूँ?

सुझाए गए प्रश्न:

दिन की सीमा

पिछला बंद

52-सप्ताह रेंज

बाजार पूंजीकरण

वॉल्यूम

बेसिक ईपीएस (टीटीएम)

पीई अनुपात

अवलोकन तकनीकी रणनीतियाँ वित्तीय खबरें

News

NVS Wins FDA Nod for Label Expansion of Immunology Drug Rhapsido

Zacks Investment Research8 अक्टूबर 2026

NVS Wins FDA Nod for Label Expansion of Immunology Drug Rhapsido

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS

PRNewsWire8 अक्टूबर 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS

US FDA expands use of Novartis drug for chronic skin condition

Reuters7 अक्टूबर 2026

US FDA expands use of Novartis drug for chronic skin condition

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS

GlobeNewsWire6 अक्टूबर 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS

NVS

Novartis AG

NVSNYSE

$143.75$0.64(0.45%)के अनुसार कल पर 20:00 UTC

बारे में Novartis AG

क्षेत्र

Healthcare

उद्योग

Drug Manufacturers - General

देश

CH

वेबसाइट

www.novartis.com

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.